0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Antibody > Rabbit MAb Antibody > CD7 / LEU9 Antibody

CD7 / LEU9 Antibody PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
50393-R017
  YES          

Mouse CD7 / LEU9 Antibody

  Order or Inquire for CD7 Antibody product
  Detection limit is 2 ng/lane in WB
  Detection limit is 0.00245 ng/well in ELISA
 

CD7 / LEU9 Antibody Product Information

Immunogen :

Recombinant mouse CD7 protein ( Catalog#50393-M08H )

Antibody Type : Rabbit Monoclonal Antibody ( Rabbit mAb Service Platform )

Clone ID :

017

Ig Type :

Rabbit IgG

Formulation : 0.2 μm filtered solution in PBS with 5% trehalose
Preparation :

This antibody was obtained from a rabbit immunized with purified, human cell-derived, recombinant mouse CD7 / LEU9 extracellular domain ( rM CD7 ; Catalog#50393-M08H ; NP_033984.1 ; Met 1 - Pro 150 ).

CD7 / LEU9 Antibody Usage Guide

Specificity :

Mouse CD7 / LEU9

Western blot : This antibody can be used at 1 - 2 μg/mL with the appropriate secondary reagents to detect mouse CD7 in WB. Using a DAB detection system, the detection limit for mouse CD7 is approximately 2 ng/lane under non-reducing conditions and reducing conditions
Direct ELISA : This antibody can be used at 0.1 - 0.2 μg/mL with the appropriate secondary reagents to detect mouse CD7. The detection limit for mouse CD7 is approximately  0.00245 ng/well
Storage : This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

CD7 / LEU9 Antibody Related Products & Topics

Related Areas:

Immunology>>Cluster of Differentiation>>Natural Killer (NK) Cell CD Antigen>> CD7

Proteins:

Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CD7 Human CD7 Protein, Recombinant 11028-H08H
CD7 Mouse CD7 Protein, Recombinant 50393-M08H

Antibodies:

Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human
CD7
WB, ELISA CD7 Antibody, Rabbit MAb 11028-R015
Human
CD7
WB, ELISA Rabbit Polyclonal Antibody 11028-RP01
Human
CD7
WB, ELISA Rabbit Polyclonal Antibody (Antigen Affinity Purified) 11028-RP02
Mouse
CD7
WB, ELISA CD7 Antibody, Rabbit MAb 50393-R017
Mouse
CD7
WB, ELISA Rabbit Polyclonal Antibody 50393-RP01
Mouse
CD7
WB, ELISA Rabbit Polyclonal Antibody (Antigen Affinity Purified) 50393-RP02

CD7 / LEU9 Antibody Background

T-cell antigen CD7, also known as T-cell surface antigen Leu-9, and CD7, is a single-pass type I membrane protein. It is expressed on human T and NK cells, as well as on cells in the early stages of T, B, and myeloid cell differentiation. CD7 is a T cell-associated antigen which appears early in ontogeny and persists on circulating T cells. It appears to have a significant role in T cell development and function. The precise mechanism by which this molecule mediates its effect is not known. CD7-mediated signals appear to augment function of adhesion molecules on NK cells, which may be involved in NK cell activation by providing both anchorage and costimulatory triggering. The CD7 molecule is a differentiation antigen found on the surface of T lymphocytes and also on a very minor fraction of acute nonlymphocytic leukemia (ANLL). CD7 is highly expressed on malignant immature T cells and is generally absent on malignant mature T cells, such as CD4+ Sezary leukemia and HTLV-1+ adult T-cell leukemia cells. Studies in CD7-deficient mice have provided insights into CD7 function, and demonstrated key roles for CD7 in regulating peripheral T and NK cell cytokine production and sensitivity to LPS-induced shock syndromes.

References

  1. Rabinowich, H. et al., 1994, J Immunol. 152 (2): 517-26.
  2. Leta, E. et al., 1995, Cell Immunol. 165 (1): 101-9.
  3. Polskj, JM. et al., 2000, Leuk Lymphoma. 39 (5-6): 633-9.
  4. Stillwell, R. et al., 2002, Immunol. Res. 24 (1): 31-52.
  5. Murphy, M. et al., 2002, Am J Dermatopathol. 24 (1): 6-16.